Dr. Nataliya Uboha sat down to discuss the early warning signs of esophageal cancer, as well as important key takeaways for those with the disease.
Dr. Nataliya Uboha
Advertisement
Articles by Dr. Nataliya Uboha
Krazati plus Erbitux is well tolerated in KRAS G12C-mutant metastatic colorectal cancer, with manageable side effects and less immune suppression.
Dr. Nataliya Uboha explained the benefit of treatment with Krazati combined with Erbitux in KRAS G12C–mutant metastatic colorectal cancer.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CURE
1
FDA Grants Exousia Pro Orphan Drug Designation in Glioma
2
With Cancer, 'Your Outlook Will be Significant in Beating this Disease'
3
What to Know About the FDA Approval of Blenrep for Multiple Myeloma
4
Advancing Research Offers Hope for Patients With Liver Cancer
5
